BGICC 2019
BGICC 2019
We 'should' test next generation sequencing on metastatic breast cancer patients
A discussion on cancer in the elderly
We 'shouldn't' test next generation sequencing on metastatic breast cancer patients
Positive feedback of clinical trials, research and patient outcomes
Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence and outcome
When to increase and decrease burden of treatment for breast cancer patients
APT for HER2 breast cancer patients with small tumours
Can we cure cervical cancer?
History and current status of breast cancer treatment in Sweden
New FIGO staging in vulval and cervical cancer
Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical practice?
Superparamagnetic iron oxide nanoparticles for sentinel node biopsy
Surgical choices for early breast cancer: a cross-sectional survey in 110 hospitals in mainland China
Breast conservation and neoadjuvant chemotherapy in breast cancer
SLNB after neoadjuvant chemotherapy
Fertility issues during adjuvant treatment in premenopausal breast cancer patients
Palliative care in Africa
Stereotactic body radiation therapy for oligometastatic breast cancer
The BCIGG 2019 conference and future prospects
How to enhance pCR in TNBC
Improvements in breast cancer detection
Risk based screening protocols for the detection of breast cancer
Effect of fatigue in breast cancer patients
Endocrine manipulations in premenoupausal metastatic HER2 positive breast cancer: breaking the silence
Management of patients progressing on CDK inhibitors
Predictor factors of lymphedema: Recent discoveries
Breast radiation after neoadjuvant chemotherapy?
The importance of early detection of breast cancer in young patients
Best practice guidelines in the management of nipple discharge
Education and innovation in surgical oncology
Inhibiting MDM2 to promote apoptosis in ALL